Zelira Therapeutics: Funding, Investors & Team (Sep 2026)
Leading worldwide therapeutic medicinal cannabis firm Zelira Therapeutics Ltd. (formerly Zelda Therapeutics) has access to the biggest and fastest-growing cannabis markets in the world. wwwzeliratxcom
Zelira Therapeutics has raised $8.6M across 1 funding round on record, the most recent an undisclosed round of $8.6M announced in Feb 2023.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Zelira Therapeutics Company Profile and Key Stats
Latest funding round on record: Feb 2023.
Zelira Therapeutics Funding Rounds
Zelira Therapeutics Founders and Leadership Team
Contact details for the Zelira Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Zelira Therapeutics Funding Compared to Other Biotechnology Startups
Zelira Therapeutics' latest round of $8.6M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Zelira Therapeutics in Biotechnology and Perth
Companies Similar to Zelira Therapeutics
AdvanCell is a company that focuses on developing innovative cancer treatments using alpha-emitting isotopes…
The objective of Fluent is to seamlessly integrate humans with AI, improving interaction and communication…
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's…
Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services…
Algenie was founded on a simple realization: algae has the potential to save the earth, but only if it is…
Paradigm Pharmaceuticals is a global biopharmaceutical company driven to discover, develop, and deliver…
Imugene is a publicly-listed biotechnology company with operations in America and Europe,
BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing…
Cauldron Ferm is a technique that speeds up the production of precision fermented prototypes to commercial…
HydGene Renewables is developing a biotechnology platform that produces on-site green hydrogen from waste…
Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more…
Zelira Therapeutics Funding FAQs
What does Zelira Therapeutics do?
Leading worldwide therapeutic medicinal cannabis firm Zelira Therapeutics Ltd. (formerly Zelda Therapeutics) has access to the biggest and fastest-growing cannabis markets in the world. wwwzeliratxcom
How much funding has Zelira Therapeutics raised?
Zelira Therapeutics has raised $8.6M across 1 round on record. The most recent is an undisclosed round of $8.6M announced in Feb 2023.
When did Zelira Therapeutics last raise funding?
Zelira Therapeutics' most recent funding round on record is an undisclosed round of $8.6M, announced in Feb 2023.
Who is the CEO of Zelira Therapeutics?
Oludare Odumosu is listed as CEO at Zelira Therapeutics.
Where is Zelira Therapeutics headquartered?
Zelira Therapeutics is based in Perth, Western Australia, Australia.
How many employees does Zelira Therapeutics have?
Zelira Therapeutics is in the 1-10 employee band.
How does Zelira Therapeutics' funding compare to other Biotechnology startups?
Zelira Therapeutics' latest round of $8.6M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Zelira Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Zelira Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.